Overview
Belgian chemical maker's Q1 revenue fell 8.5% organically on soft volumes and pricing pressures
Q1 underlying EBITDA declined 10.1% organically, margin at 21.9%
Company maintained free cash flow in line with normal seasonality
Outlook
Solvay expects 2026 underlying EBITDA between €770 mln and €850 mln
Company sees 2026 free cash flow of at least €200 mln, net of transformation expenses
Solvay does not expect operating environment to improve in short term
Result Drivers
SOFT VOLUMES AND PRICING PRESSURES - Co said Q1 revenue decline reflected soft volumes across most businesses and pricing pressures, especially in soda ash and Coatis
ONE-OFF GAINS AND PORTFOLIO OPTIMIZATION - Q1 EBITDA was supported by a one-off litigation gain and further optimization of Solvay’s CO2 portfolio
STRUCTURAL COST SAVINGS - Structural cost savings initiatives delivered €22 million in Q1 2026, contributing to operational resilience
Company press release: ID:nGNE6MGtB2
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
EUR 997 mln
Q1 EBITDA
EUR 219 mln
Q1 EBITDA Margin
21.90%
Q1 Free Cash Flow
EUR 26 mln
Q1 ROCE
13.20%
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 7 "hold" and 7 "sell" or "strong sell"
The average consensus recommendation for the diversified chemicals peer group is "buy."
Wall Street's median 12-month price target for Solvay SA is €26.00, about 9.9% below its May 6 closing price of €28.86
The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 9 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)